Study tests if one drug can replace two for inflammatory bowel disease

NCT ID NCT07564609

ENROLLING_BY_INVITATION Disease control Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether using just one medication (infliximab) under the skin works as well as using it together with another immune-suppressing drug for people with Crohn's disease or ulcerative colitis. About 420 adults who have already started infliximab will be followed for at least 3 months. The goal is to see if the simpler approach can keep symptoms away without needing steroids.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN DISEASE (CD) ULCERATIVE COLITIS (UC)

Contacts and locations

Locations

CHU Amiens

Amiens, France
CHU Besançon

Besançon, France
CHU Clermont Ferrand

Clermont-Ferrand, 63000, France
CHU Dijon

Dijon, France
CHU Grenoble

Grenoble, France
CHU Lille

Lille, France
CHU Monptellier

Montpellier, France
CHU Nancy

Nancy, France
CHU Nantes

Nantes, France
CHU Nîmes

Nîmes, France
CHU Rouen

Rouen, France
CHU Toulouse

Toulouse, France
Hospice Civil de Lyon

Lyon, France
Hôpital Beaujon AP-HP

Clichy, France
Hôpital Bicêtre AP-HP

Le Kremlin-Bicêtre, France
Hôpital Henri-Mondor AP-HP

Créteil, France
Hôpital Henri-Mondor AP-HP

Marseille, France
Institut des MICI

Neuilly-sur-Seine, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.